Journal article icon

Journal article

Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?

Abstract:

Alemtuzumab (Campath-1H) has been widely used for T-cell depletion following both conventional and reduced-intensity conditioning allografts. We studied the impact of alemtuzumab used in vivo and in vitro on infections, immune reconstitution, and allograft outcome. The use of alemtuzumab in vivo following reduced-intensity conditioning and unrelated donor conventional transplantation was associated with durable engraftment and significant reduction in graft-versus-host disease (GVHD) but at t...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pathology Dunn School
Role:
Author
Journal:
Transplantation proceedings
Volume:
36
Issue:
5
Pages:
1225-1227
Publication date:
2004-06-01
DOI:
EISSN:
1873-2623
ISSN:
0041-1345
Source identifiers:
9804
Language:
English
Keywords:
Pubs id:
pubs:9804
UUID:
uuid:d2c17132-aef2-4c9b-b2d5-dbf51fdc5344
Local pid:
pubs:9804
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP